It really is mind-boggling. Most bio companies would be thrilled to have as much data/test/trials etc that confirms their product/substance was of value. Heck, one could argue they would be happy with a fraction of what ZIVO has. Especially since NONE of it is negative.
Yet, here we sit...with a company that holds a literal Golden Ticket...and they can't even figure out how to cash it in. Pathetic.
News 
Market Data 
Discover 
